Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phil Lieberman

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Allergy and Asthma Proceedings|March 4, 2020
Mast cell disorders and idiopathic anaphylaxis: Evaluation and managementMuhammad Bilal Khalid, Phil Lieberman
Current Opinion in Allergy and Clinical Immunology|June 26, 2015
Epinephrine in anaphylaxis: doubt no moreT Ted Song, Phil Lieberman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 9, 2006
Anaphylaxis: a review of 601 casesLuke M Webb, Phil Lieberman
Cleveland Clinic Journal of Medicine|January 10, 2019
Who needs to carry an epinephrine autoinjector?T Ted Song, Phil Lieberman
Immunology and Allergy Clinics of North America|May 12, 2007
Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendationsJohn W Tole, Phil Lieberman
The Journal of Allergy and Clinical Immunology. in Practice|May 7, 2019
ReplyT Ted Song, Phil Lieberman
Medical Economics|August 25, 2015
Clinical Economics Allergic RhinitisNicole Klemas, Phil Lieberman, Renee Dowling
Future Cardiology|August 9, 2012
Aspirin sensitivity and coronary artery disease: implications for the practicing cardiologistDebendra Pattanaik, Phil Lieberman, Pranab Das
The Journal of Allergy and Clinical Immunology. in Practice|January 8, 2018
Allergists' opinions on anaphylaxis and epinephrine administration-a case-based surveyJay A Lieberman, Phil Lieberman, Julie Wang
Current Medical Research and Opinion|May 19, 2005
Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitisPhil Lieberman, Michael A Kaliner, William J Wheeler
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Allergy and Asthma Proceedings|March 4, 2020
Mast cell disorders and idiopathic anaphylaxis: Evaluation and managementMuhammad Bilal Khalid, Phil Lieberman
Current Opinion in Allergy and Clinical Immunology|June 26, 2015
Epinephrine in anaphylaxis: doubt no moreT Ted Song, Phil Lieberman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 9, 2006
Anaphylaxis: a review of 601 casesLuke M Webb, Phil Lieberman
Cleveland Clinic Journal of Medicine|January 10, 2019
Who needs to carry an epinephrine autoinjector?T Ted Song, Phil Lieberman
Immunology and Allergy Clinics of North America|May 12, 2007
Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendationsJohn W Tole, Phil Lieberman
The Journal of Allergy and Clinical Immunology. in Practice|May 7, 2019
ReplyT Ted Song, Phil Lieberman
Medical Economics|August 25, 2015
Clinical Economics Allergic RhinitisNicole Klemas, Phil Lieberman, Renee Dowling
Future Cardiology|August 9, 2012
Aspirin sensitivity and coronary artery disease: implications for the practicing cardiologistDebendra Pattanaik, Phil Lieberman, Pranab Das
The Journal of Allergy and Clinical Immunology. in Practice|January 8, 2018
Allergists' opinions on anaphylaxis and epinephrine administration-a case-based surveyJay A Lieberman, Phil Lieberman, Julie Wang
Current Medical Research and Opinion|May 19, 2005
Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitisPhil Lieberman, Michael A Kaliner, William J Wheeler
Pageof 6